To further confirm that ligation of NKG2C with HLA-E can overcome inhibitory KIR-signaling the primary GBM cell line HT18584 was genetically modified with HLA-E*spG to generate HT18584-HLA-E*spG cells. The gene discussed is KIR3DL1; the disease is glioblastoma.